Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)

✍ Scribed by Emons, Günter; Gorchev, Grigor; Sehouli, Jalid; Wimberger, Pauline; Stähle, Anne; Hanker, Lars; Hilpert, Felix; Sindermann, Herbert; Gründker, Carsten; Harter, Philipp

• Book ID: 122113277
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 175 KB
• Volume: 133
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.03.576